Julie Burek

Julie Burek has extensive experience in finance and financial planning. Julie is currently serving as the Vice President of Financial Planning & Analysis at BlueRock Therapeutics since April 2023. Prior to this, they held various roles at Voyager Therapeutics, Inc., including Vice President of Finance from August 2020 to March 2023, Senior Director of Finance from August 2019 to July 2020, and Director of Financial Planning & Analysis from April 2018 to July 2019. Julie also worked as an Associate Director of Finance at Biogen from February 2013 to March 2018 and as a Senior Finance Manager at EMD Serono from January 2008 to February 2013. Julie gained experience as a Financial Analysis Director at Hill Holliday from January 2007 to January 2008 and as an Associate Director of Finance at Digitas, Inc. from an unspecified date in 2000 to January 2007. Julie's career began as a Financial Analyst at Teradyne in 1996.

Julie Burek obtained their MBA degree from the D'Amore-McKim School of Business at Northeastern University from 1997 to 1999. Prior to that, they attended Bentley University from 1992 to 1996. Additional information about their education at Bentley University is not provided.